Search research articles
Contact Us
Filters
Showing results (251-260 of 337) with videos related to
Page
of 34
Sort By:
Arthritis and Rheumatism
|
October 11, 2001
Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis
S Ballara, P C Taylor, P Reusch, et al.
British Journal of Rheumatology
|
June 1, 1997
Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy
F M Brennan, K A Browne, P A Green, et al.
Journal of Leukocyte Biology
|
April 1, 1991
Function and regulation of the murine lymphocyte CD2 receptor
D J Abraham, G Bou-Gharios, J R Beauchamp, et al.
Annals of the Rheumatic Diseases
|
December 1, 1999
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis
R N Maini, P C Taylor, E Paleolog, et al.
Clinical and Experimental Rheumatology
|
March 1, 1989
Anti-La (SS-B): a diagnostic criterion for Sjögren's syndrome?
P J Venables, W Shattles, C T Pease, et al.
Clinical and Experimental Immunology
|
December 1, 1991
Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction
C Q Chu, M Field, E Abney, et al.
Clinical and Experimental Immunology
|
June 1, 1983
In vitro immunoglobulin synthesis by lymphocytes from patients with rheumatoid arthritis. I. Effect of monocyte depletion and demonstration of an increased proportion of lymphocytes forming rosettes with mouse erythrocytes
C Plater-Zyberk, M F Clarke, K Lam, et al.
Clinical and Experimental Immunology
|
January 1, 1983
Separation of two molecular species of the Sm antigen by affinity chromatography with murine monoclonal and human anti-nuclear autoantibodies
R R Buchanan, P J Venables, A Morgan, et al.
Clinical and Experimental Rheumatology
|
December 10, 1999
Combination therapy with DMARDs and biological agents in collagen-induced arthritis
R O Williams, A M Malfait, D M Butler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 1999
The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action
A M Malfait, A S Malik, L Marinova-Mutafchieva, et al.
Page
of 34
Search research articles
Search
Showing results (251-260 of 337) with videos related to
Sort By:
Page
of 34
Arthritis and Rheumatism
|
October 11, 2001
Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis
S Ballara, P C Taylor, P Reusch, et al.
British Journal of Rheumatology
|
June 1, 1997
Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy
F M Brennan, K A Browne, P A Green, et al.
Journal of Leukocyte Biology
|
April 1, 1991
Function and regulation of the murine lymphocyte CD2 receptor
D J Abraham, G Bou-Gharios, J R Beauchamp, et al.
Annals of the Rheumatic Diseases
|
December 1, 1999
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis
R N Maini, P C Taylor, E Paleolog, et al.
Clinical and Experimental Rheumatology
|
March 1, 1989
Anti-La (SS-B): a diagnostic criterion for Sjögren's syndrome?
P J Venables, W Shattles, C T Pease, et al.
Clinical and Experimental Immunology
|
December 1, 1991
Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction
C Q Chu, M Field, E Abney, et al.
Clinical and Experimental Immunology
|
June 1, 1983
In vitro immunoglobulin synthesis by lymphocytes from patients with rheumatoid arthritis. I. Effect of monocyte depletion and demonstration of an increased proportion of lymphocytes forming rosettes with mouse erythrocytes
C Plater-Zyberk, M F Clarke, K Lam, et al.
Clinical and Experimental Immunology
|
January 1, 1983
Separation of two molecular species of the Sm antigen by affinity chromatography with murine monoclonal and human anti-nuclear autoantibodies
R R Buchanan, P J Venables, A Morgan, et al.
Clinical and Experimental Rheumatology
|
December 10, 1999
Combination therapy with DMARDs and biological agents in collagen-induced arthritis
R O Williams, A M Malfait, D M Butler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 1999
The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action
A M Malfait, A S Malik, L Marinova-Mutafchieva, et al.
Page
of 34